<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T16:06:19.5832543+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-KGZ-C-UNDP-2</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Effective HIV and TB control project in Kyrgyzstan - Kyrgyzstan (01-Jul-2018-31-Dec-2020)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Kyrgyzstan, TB/HIV, United Nations Development Programme (UNDP Kyrgyzstan)This program has the following goals: To minimize the impact of the HIV epidemic by reducing 50% of the incidence and mortality by 2021 compared to 2015, as a stage towards eliminating the epidemic in the Kyrgyz Republic by 2030..  Success of treatment among sensitive forms of TB is achieved 85%, among drug resistant forms of MDR-TB by 2020, 67% according to NTP-5.. The objectives of this program are: Reduce the number of new HIV infections, especially among key populations by 50% by 2021 compared to 2015..  Ensure that 90% of people living with HIV (PLHIV) are aware of their HIV status..  Cover 90% of people living with HIV with antiretroviral therapy (ART) and achieve viral load suppression in 90% of people receiving ART by 2021..  Achieve a reduction to less than 2% of mother-to-child transmission of HIV, which will lead to its elimination by 2021..  To reduce the level of stigma and discrimination to zero in government organizations providing HIV-related services to key populations and PLHIV..  Reduce to zero the number of laws, other regulations and practices that discriminate against people living with HIV and key populations..  Ensure coordination and sustainable financing of HIV response measures by gradually increasing the share of government funding for HIV prevention and treatment programs to 50% by 2021..  To ensure universal access to timely and quality diagnosis and treatment of all forms of TB including M/XDR-TB</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="KGZ-C-UNDPP02" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2018-07-01" />
		<activity-date type="2" iso-date="2018-07-01" />
		<activity-date type="3" iso-date="2020-12-31" />
		<activity-date type="4" iso-date="2020-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Valeria, GRISHECHKINA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>valeria.grishechkina@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="KG" percentage="100">
			<narrative xml:lang="en">Kyrgyzstan</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="26">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="26">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="2">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="46">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for MSM -&gt; Behavioral interventions for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for MSM -&gt; Condoms and lubricant programming for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for MSM -&gt; HIV testing services for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; Condoms and lubricant programming for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; HIV testing services for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; Needle and Syringe programs for PWID and their partners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; OST and other drug dependence treatment for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; Overdose prevention and management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Behavioral interventions for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Condoms and lubricant programming for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; HIV testing services for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive programs for people in prisons and other closed settings -&gt; Behavioral interventions for people in prisons and other closed settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive programs for people in prisons and other closed settings -&gt; HIV testing services for people in prisons and other closed settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 4: Treatment, care and support to mothers living with HIV, their children and families</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for other vulnerable populations -&gt; HIV testing services for other vulnerable populations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment adherence</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 control and containment including health systems strengthening</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Risk mitigation for disease programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="22">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="11">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="32">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2018-01-01" />
			<period-end iso-date="2018-12-31" />
			<value currency="USD" value-date="2018-07-01">3229329.58</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2020-01-01" />
			<period-end iso-date="2020-12-31" />
			<value currency="USD" value-date="2018-07-01">14080313.19</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2019-01-01" />
			<period-end iso-date="2019-12-31" />
			<value currency="USD" value-date="2018-07-01">8710212.69</value>
		</budget>
		<transaction ref="10e56d9f-02c5-4047-9aa6-2d493631cb30">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-05-20" />
			<value currency="USD" value-date="2019-05-20">-25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="df8442fe-b83b-4d67-b80a-c29207546648">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-05-13" />
			<value currency="USD" value-date="2020-05-13">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a3d5b78e-d5d8-47f9-9239-e9d147b77e03">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-01-09" />
			<value currency="USD" value-date="2019-01-09">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e6ae328c-f474-4dec-bd68-c51b71e503b9">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-09-24" />
			<value currency="USD" value-date="2020-09-24">933375.61</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7551a803-2136-4599-bfd1-c20e0087611f">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-05-12" />
			<value currency="USD" value-date="2020-05-12">6015055.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e421a0ab-c72c-44f4-8f6e-248299091b02">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-08-21" />
			<value currency="USD" value-date="2019-08-21">3960276.59</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ec8d11f8-6e77-44fd-b170-90341e77efc1">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-07-16" />
			<value currency="USD" value-date="2018-07-16">12361316.41</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="738240c8-7ceb-4673-8188-3f69374ab928">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-05-20" />
			<value currency="USD" value-date="2019-05-20">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ae00475e-ab3d-4d8a-a79c-75811b9ad4f9">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-12-16" />
			<value currency="USD" value-date="2021-12-16">-8094.83</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2f3f3f48-5525-4f76-afee-e04f6676fd8a">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-10-10" />
			<value currency="USD" value-date="2019-10-10">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="da639b25-41a9-4b9e-bfd5-8e199f9338e6">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-01-07" />
			<value currency="USD" value-date="2020-01-07">845595.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e0c73830-e61f-4deb-a504-8405f8939a71">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-10-01" />
			<value currency="USD" value-date="2019-10-01">959364.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="19ccf5e1-3054-4b57-bd88-694c75b3b156">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-10-02" />
			<value currency="USD" value-date="2020-10-02">933375.61</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2932e22e-5850-4640-ba41-125b262f7db9">
			<transaction-type code="7" />
			<transaction-date iso-date="2021-12-13" />
			<value currency="USD" value-date="2021-12-13">-8094.83</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="126f69ac-3607-4486-8b23-f5ec8966a679">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-04-01" />
			<value currency="USD" value-date="2021-04-01">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8626baab-3a11-455e-816b-dc8440505dd8">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-07-02" />
			<value currency="USD" value-date="2020-07-02">515055.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ab3780ca-c4d5-4b7a-94bb-69e8b2b9e86c">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-05-19" />
			<value currency="USD" value-date="2020-05-19">5500000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9416490a-0662-4755-9abe-2d14494d02d0">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-01-08" />
			<value currency="USD" value-date="2019-01-08">1043454.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="84fa5d02-316b-4ed2-a555-f88815583d90">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-08-22" />
			<value currency="USD" value-date="2019-08-22">1769345.59</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="516b6c84-9453-4ceb-a5b9-06f0f0be364b">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-04-02" />
			<value currency="USD" value-date="2019-04-02">2034573.41</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="366ecd03-21b5-4723-ae36-ca45d204652e">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-07-17" />
			<value currency="USD" value-date="2018-07-17">8201386.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b8834059-b969-4304-8449-e679468e6757">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-10-04" />
			<value currency="USD" value-date="2018-10-04">1081903.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ba38ed38-5a4f-4b3c-b345-776a3eb0d61d">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-04-02" />
			<value currency="USD" value-date="2020-04-02">385972.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/KGZ-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for KGZ-C-UNDPP02</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="740" />
					<actual value="369" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="740" />
					<actual value="733" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="700" />
					<actual value="850" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="720" />
					<actual value="709" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="720" />
					<actual value="731" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases of XDR TB enrolled on treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="42" />
					<actual value="45" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="53" />
					<actual value="54" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="53" />
					<actual value="48" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="66" />
					<actual value="42" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="66" />
					<actual value="21" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="62.75" />
					<actual value="56.60" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="67.17" />
					<actual value="56.10" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="70.00" />
					<actual value="63.00" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="60.00" />
					<actual value="55.00" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="65.00" />
					<actual value="54.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="95.00" />
					<actual value="99.20" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="95.00" />
					<actual value="95.70" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="95.00" />
					<actual value="95.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="95.00" />
					<actual value="96.40" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="95.00" />
					<actual value="97.80" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="95.00" />
					<actual value="96.30" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="95.00" />
					<actual value="97.40" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="95.00" />
					<actual value="87.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="35.84" />
					<actual value="40.80" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="40.96" />
					<actual value="42.60" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="35.84" />
					<actual value="31.70" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="40.96" />
					<actual value="41.30" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="33.73" />
					<actual value="33.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="42.08" />
					<actual value="40.70" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="42.08" />
					<actual value="26.70" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="35.62" />
					<actual value="34.00" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="35.62" />
					<actual value="37.80" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="23.89" />
					<actual value="29.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="33.72" />
					<actual value="20.10" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="33.72" />
					<actual value="27.70" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="35.97" />
					<actual value="18.70" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="31.49" />
					<actual value="31.20" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="35.97" />
					<actual value="22.40" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="79.20" />
					<actual value="81.80" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="57.30" />
					<actual value="72.70" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="68.25" />
					<actual value="82.20" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="93.57" />
					<actual value="94.50" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="86.38" />
					<actual value="85.90" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of confirmed MDR-TB cases tested for susceptibility to any fluoroquinolone and any second-line injectable drug</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="70.00" />
					<actual value="68.90" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="60.00" />
					<actual value="65.40" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="75.00" />
					<actual value="78.30" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="55.00" />
					<actual value="52.00" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="65.00" />
					<actual value="66.40" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="3400" />
					<actual value="1743" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="3450" />
					<actual value="3241" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="3500" />
					<actual value="3191" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="3475" />
					<actual value="3023" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="3425" />
					<actual value="2965" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV and on ART, who have a suppressed viral load at 12 months (&lt;1000 copies/ml)</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="55.00" />
					<actual value="68.40" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="79.00" />
					<actual value="86.70" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="67.00" />
					<actual value="79.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="69.97" />
					<actual value="61.40" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="74.97" />
					<actual value="53.20" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="79.97" />
					<actual value="48.90" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="72.48" />
					<actual value="50.70" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="77.47" />
					<actual value="49.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="90.00" />
					<actual value="94.80" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="90.00" />
					<actual value="92.60" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="90.00" />
					<actual value="97.40" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="90.00" />
					<actual value="91.70" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.00" />
					<actual value="100.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="740" />
					<actual value="606" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="700" />
					<actual value="671" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="720" />
					<actual value="674" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="740" />
					<actual value="327" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="720" />
					<actual value="665" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="51.45" />
					<actual value="48.90" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="63.31" />
					<actual value="47.70" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="80.96" />
					<actual value="44.40" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="71.82" />
					<actual value="43.30" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="55.23" />
					<actual value="44.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="93.00" />
					<actual value="94.10" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="90.00" />
					<actual value="92.60" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="91.00" />
					<actual value="92.20" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="92.00" />
					<actual value="94.60" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="95.00" />
					<actual value="94.40" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="31.50" />
					<actual value="32.70" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="31.50" />
					<actual value="33.90" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="33.75" />
					<actual value="38.40" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="33.75" />
					<actual value="24.40" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="29.25" />
					<actual value="34.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="75.00" />
					<actual value="66.50" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="70.00" />
					<actual value="64.80" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="72.50" />
					<actual value="65.30" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="65.00" />
					<actual value="66.10" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="67.50" />
					<actual value="63.30" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for KGZ-C-UNDPP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="82.00" />
					<actual value="76.70" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="83.00" />
					<actual value="86.82" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="115" />
					<actual value="99.2" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="114" />
					<actual value="99.2" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="115" />
					<actual value="94.09" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="114" />
					<actual value="94.09" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="63.00" />
					<actual value="50.90" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="65.00" />
					<actual value="55.48" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="82.00" />
					<actual value="76.90" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="85.00" />
					<actual value="77.73" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="85.00" />
					<actual value="4728" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="85.50" />
					<actual value="4321" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for KGZ-C-UNDPP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB I-Other 1: RR-TB and or MDR/TB prevalence among previously treated TB patients: Proportion of previously treated TB cases with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="60.00" />
					<actual value="67.77" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="60.00" />
					<actual value="60.12" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of AIDS-related deaths per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="1.21" />
					<actual value="1.16" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="1.22" />
					<actual value="1.16" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="1.21" />
					<actual value="0.48" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="1.22" />
					<actual value="0.48" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="27.00" />
					<actual value="28.90" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="26.50" />
					<actual value="29.50" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="5.3" />
					<actual value="4.6" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="5.4" />
					<actual value="4.6" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="5.4" />
					<actual value="3.88" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="5.3" />
					<actual value="3.88" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-KGZ-C-UNDP-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">HIV/TB - Kyrgyzstan (01-Jul-2016-30-Jun-2018)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Kyrgyzstan, TB/HIV, United Nations Development Programme (UNDP Kyrgyzstan)This program has the following goals: To reduce TB and HIV burden in Kyrgyzstan through ensuring universal access to timely and quality TB diagnosis and treatment, implementing evidence based HIV preventive activities focused primarily on key affected populations, providing treatment, care and support to PLHIV, creating enabling environment and ensuring programs sustainability.. The objectives of this program are: To create enabling environment and ensure programs sustainability.  To ensure universal access to timely and quality diagnosis and treatment of all forms of TB including M/XDR-TB.  To implement evidence-based HIV preventive activities focused primarily on key affected populations and provide treatment, care and support to PLHIV</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="KGZ-C-UNDPP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2016-07-01" />
		<activity-date type="2" iso-date="2016-07-01" />
		<activity-date type="3" iso-date="2018-06-30" />
		<activity-date type="4" iso-date="2018-06-30" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Valeria, GRISHECHKINA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>valeria.grishechkina@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="KG" percentage="100">
			<narrative xml:lang="en">Kyrgyzstan</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="100">
			<narrative xml:lang="en">TB/HIV</narrative>
		</sector>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<transaction ref="e6c70e11-724d-4c6e-b405-07d32c134ee9">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-03-27" />
			<value currency="USD" value-date="2018-03-27">100000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="16fddef2-623b-4aa0-8202-5a0c03438c12">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-01-09" />
			<value currency="USD" value-date="2019-01-09">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3fa18fd9-e109-47cf-82a3-d540101ec5a2">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-02-19" />
			<value currency="USD" value-date="2018-02-19">-241948.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d89c43d2-17c0-484c-976e-81633baf77af">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-08-16" />
			<value currency="USD" value-date="2018-08-16">-70000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="83cba085-3503-4a8b-a7f6-ae341618d074">
			<transaction-type code="2" />
			<transaction-date iso-date="2016-08-19" />
			<value currency="USD" value-date="2016-08-19">18617455.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5987e53e-c04e-49af-b719-f64beb6e37bb">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-02-19" />
			<value currency="USD" value-date="2018-02-19">3509263.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="548d2c7b-6dca-4822-9e50-a48146193b27">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-07-16" />
			<value currency="USD" value-date="2019-07-16">-25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="39c610c8-4787-4eb5-932e-9be3be6569e2">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-01-09" />
			<value currency="USD" value-date="2019-01-09">-50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="42b146df-5659-4257-87d0-1a907d2e1813">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-09-16" />
			<value currency="USD" value-date="2016-09-16">3054315.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9ddc6ae3-973c-4860-a39b-1f6c1bd2788a">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-08-17" />
			<value currency="USD" value-date="2018-08-17">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1e90e463-c883-4100-9a3c-be2fc0f5f1d2">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-08-23" />
			<value currency="USD" value-date="2016-08-23">583251.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a63b4982-6fd1-4d20-b1f8-8ed2a4e39c28">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-04-13" />
			<value currency="USD" value-date="2017-04-13">6937211.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2671c259-c4b9-41a3-8b33-6f9d949358a2">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-12-06" />
			<value currency="USD" value-date="2016-12-06">2657004.91</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="daa903cd-778f-4c82-b65b-d9d2419ccf53">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-10-24" />
			<value currency="USD" value-date="2017-10-24">1419317.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0abe6965-5de7-40a7-9f98-514a490c7a63">
			<transaction-type code="7" />
			<transaction-date iso-date="2018-08-16" />
			<value currency="USD" value-date="2018-08-16">-70000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a062786e-9374-4ca0-ae8e-bace6330613b">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-10-24" />
			<value currency="USD" value-date="2017-10-24">2245043.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="926cdf8e-0e0f-4414-9b13-7bcd382f6993">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-02-27" />
			<value currency="USD" value-date="2018-02-27">3509263.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="59e9dc13-05c1-4c81-8b21-f928d2cd5aab">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-11-22" />
			<value currency="USD" value-date="2016-11-22">1479365.09</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/KGZ-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for KGZ-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="85.00" />
					<actual value="71.80" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="90.00" />
					<actual value="89.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of MSM that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="18.50" />
					<actual value="19.10" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="14.80" />
					<actual value="15.80" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="18.50" />
					<actual value="22.70" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="27.40" />
					<actual value="28.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="60.00" />
					<actual value="65.70" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="55.00" />
					<actual value="58.70" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="62.50" />
					<actual value="63.30" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="57.50" />
					<actual value="63.40" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">KP-other 1: Percentage of PWID prisoners reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="18.80" />
					<actual value="17.80" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="19.40" />
					<actual value="17.00" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="19.70" />
					<actual value="16.70" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="18.10" />
					<actual value="58.70" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of needles and syringes distributed per person who injects drugs per year by needle and syringe programs</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="240" />
					<actual value="219.91" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="110" />
					<actual value="3760078" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RLB-other 1: Number of documented key affected population human rights violations (desegregated by KAP groups)</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="350" />
					<actual value="437" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="350" />
					<actual value="497" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="350" />
					<actual value="510" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="350" />
					<actual value="509" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of new HIV-positive patients starting IPT during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="90.00" />
					<actual value="83.40" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="75.00" />
					<actual value="61.60" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="80.00" />
					<actual value="69.00" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="90.00" />
					<actual value="86.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">KP-other 1: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results (prisoners)</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="35.00" />
					<actual value="39.90" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="30.30" />
					<actual value="2713" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="33.00" />
					<actual value="43.00" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="33.00" />
					<actual value="39.40" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">MDR TB-other 2: Number of MDR/XDR/RR-TB patients on treatment receiving patient support (food, hygiene packages, money allowances) for better adherence to treatment- includes inpatient and outpatient treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="2254" />
					<actual value="1689" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="2413" />
					<actual value="1684" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="1939" />
					<actual value="1476" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="65.00" />
					<actual value="55.40" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="67.50" />
					<actual value="53.40" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="60.00" />
					<actual value="57.00" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="62.40" />
					<actual value="53.40" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of MSM reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="46.10" />
					<actual value="61.60" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="32.60" />
					<actual value="45.70" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="28.00" />
					<actual value="32.20" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="37.30" />
					<actual value="49.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="26.40" />
					<actual value="30.50" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="26.40" />
					<actual value="30.00" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="23.60" />
					<actual value="27.80" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="29.20" />
					<actual value="33.30" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TCS-other 1: Number of PLHIV reached with community care and support programme</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="1480" />
					<actual value="2851" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="2032" />
					<actual value="3029" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="1616" />
					<actual value="3117" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="1410" />
					<actual value="2514" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="28.60" />
					<actual value="23.60" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="28.60" />
					<actual value="19.00" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="22.90" />
					<actual value="15.40" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="31.50" />
					<actual value="30.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RLB-other 2: Number of organizations participating in the program Street Lawyers</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="24" />
					<actual value="24" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="22" />
					<actual value="24" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="24" />
					<actual value="22" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="20" />
					<actual value="28" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="65.00" />
					<actual value="51.00" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="70.00" />
					<actual value="49.80" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="68.00" />
					<actual value="47.20" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="70.00" />
					<actual value="46.90" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="95.00" />
					<actual value="75.00" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="90.00" />
					<actual value="105.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="90.00" />
					<actual value="93.30" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="85.00" />
					<actual value="94.60" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="88.00" />
					<actual value="95.00" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="90.00" />
					<actual value="93.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="90.00" />
					<actual value="95.10" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="95.00" />
					<actual value="71.50" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="85.00" />
					<actual value="96.30" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="95.00" />
					<actual value="74.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="93.00" />
					<actual value="96.80" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="93.00" />
					<actual value="95.60" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="93.00" />
					<actual value="98.00" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="93.00" />
					<actual value="96.50" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="712" />
					<actual value="598" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="795" />
					<actual value="601" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="662" />
					<actual value="686" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="663" />
					<actual value="702" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">MDR TB-other 1: Number of patients on the treatment of sensitive and PDR 1st line treatment receiving the motivation support</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="1677" />
					<actual value="2034" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="1677" />
					<actual value="2037" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="1677" />
					<actual value="1628" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="712" />
					<actual value="646" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="800" />
					<actual value="626" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="712" />
					<actual value="697" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="712" />
					<actual value="736" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">MDR TB-other 3: Percentage and number of patients with symptoms or signs suggestive for TB examined by Xpert MTB/RIF methodology and confirmed with active TB</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="10.00" />
					<actual value="16.50" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="8.00" />
					<actual value="18.60" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="8.00" />
					<actual value="19.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="33.30" />
					<actual value="35.20" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="37.40" />
					<actual value="38.10" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="46.20" />
					<actual value="45.40" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="29.00" />
					<actual value="32.90" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for KGZ-C-UNDPP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate per 100,000 population- bacteriologically-confirmed TB, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="43" />
					<actual value="3449" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="45" />
					<actual value="3449" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="45" />
					<actual value="59.2" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="43" />
					<actual value="59.2" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="85.00" />
					<actual value="86.07" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="85.00" />
					<actual value="86.07" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="85.00" />
					<actual value="84.00" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="85.00" />
					<actual value="84.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="110" />
					<actual value="7004" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="111" />
					<actual value="7004" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="110" />
					<actual value="111.19" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="111" />
					<actual value="111.19" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="85.00" />
					<actual value="5063" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="85.00" />
					<actual value="5063" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="85.00" />
					<actual value="4968" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="85.00" />
					<actual value="4968" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reporting using sterile injecting equipment the last time they injected</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="70.00" />
					<actual value="47.52" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reporting using a condom with their most recent client</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="95.00" />
					<actual value="97.24" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate - bacteriologically confirmed TB cases</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="85.00" />
					<actual value="2036" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="85.00" />
					<actual value="2036" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="85.00" />
					<actual value="2001" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="85.00" />
					<actual value="2001" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="70.00" />
					<actual value="57.52" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="75.00" />
					<actual value="57.52" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="75.00" />
					<actual value="55.09" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="70.00" />
					<actual value="55.09" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men reporting the use of a condom the last time they had anal sex with a male partner</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="90.00" />
					<actual value="81.09" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for KGZ-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="25.00" />
					<actual value="27.29" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="26.00" />
					<actual value="27.29" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="25.00" />
					<actual value="25.59" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="26.00" />
					<actual value="25.59" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="12.40" />
					<actual value="14.26" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="6.8" />
					<actual value="343" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="6" />
					<actual value="343" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="6.8" />
					<actual value="5.33" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="6" />
					<actual value="5.33" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="2.20" />
					<actual value="1.97" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="6.30" />
					<actual value="6.56" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-KGZ-C-UNDP-4</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Effective HIV and TB Control Project in the Kyrgyz Republic - Kyrgyzstan (01-Jan-2024-31-Dec-2026)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Kyrgyzstan, TB/HIV, United Nations Development Programme (UNDP Kyrgyzstan)This program has the following goals: To minimize the impact of the HIV epidemic by reducing 30% of the incidence and mortality by 2027 compared to 2020, as a stage towards eliminating the epidemic in the Kyrgyz Republic by 2030..  Success of treatment among drug resistant forms of MDR-TB by 2026, 80% according to NTP-6.. The objectives of this program are: Ensure that 95% of people living with HIV (PLHIV) are aware of their HIV status..  Cover 95% of people living with HIV with antiretroviral therapy (ART) and achieve viral load suppression in 95% of people receiving ART by 2026..  To reduce the level of stigma and discrimination to less than 10% in government organizations providing HIV-related services to key populations and PLHIV..  Ensure coordination and sustainable financing of HIV response measures by gradually increasing the share of government funding for HIV/ prevention and treatment programs to 80% by 2026..  Ensure coordination and sustainable financing of TB response measures by gradually increasing the share of government funding for TB prevention and treatment programs to 50% by 2026..  To ensure universal access to timely and quality diagnosis and treatment of M/XDR-TB</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="KGZ-C-UNDPP04" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="2" />
		<activity-date type="1" iso-date="2024-01-01" />
		<activity-date type="2" iso-date="2024-01-01" />
		<activity-date type="3" iso-date="2026-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Valeria, GRISHECHKINA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>valeria.grishechkina@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="KG" percentage="100">
			<narrative xml:lang="en">Kyrgyzstan</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="38">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="27">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="2">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="33">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programing for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programing for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; Condom and lubricant programing for prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; HIV prevention communication, information and demand creation for prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Needle and syringe programs for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programing for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programing for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; HIV prevention communication, information and demand creation for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring rights-based law enforcement practices</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Increasing access to justice (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced disease (adults and children)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="27">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; National health sector strategy, policy &amp; regulations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Operational Research</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="20">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="14">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2024-01-01">9081461.23</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2024-01-01">6929870.90</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2026-01-01" />
			<period-end iso-date="2026-12-31" />
			<value currency="USD" value-date="2024-01-01">8551170.56</value>
		</budget>
		<transaction ref="579dee5f-4463-4b18-ab45-eb50c55ee27e">
			<transaction-type code="2" />
			<transaction-date iso-date="2026-01-27" />
			<value currency="USD" value-date="2026-01-27">3259528.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="343ecc15-eef0-45f6-bcb2-29e17e54e59e">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-01-10" />
			<value currency="USD" value-date="2024-01-10">13361931.57</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="36cf5ce3-d235-4303-8697-0f97e1d4e5f4">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-06-21" />
			<value currency="USD" value-date="2025-06-21">4423179.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1cee58ca-e262-418c-8ffe-6a2e5b669ac4">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-06-21" />
			<value currency="USD" value-date="2025-06-21">-2699416.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a848cea0-3a9c-42cd-a3c5-507a3a97a3bc">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-02-06" />
			<value currency="USD" value-date="2025-02-06">2158726.66</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f8b12c4d-da5f-4a48-bfe4-1afebc6863a5">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-07-01" />
			<value currency="USD" value-date="2025-07-01">4423179.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d0b6a59c-0457-4102-a4dc-c14586fee73f">
			<transaction-type code="3" />
			<transaction-date iso-date="2026-02-03" />
			<value currency="USD" value-date="2026-02-03">3259528.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="eae8ceee-3b39-4eda-8122-d9fb5969dfec">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-01-16" />
			<value currency="USD" value-date="2024-01-16">8503788.91</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/KGZ-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-KGZ-C-UNDP-3</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Effective HIV and TB control project in the Kyrgyz Republic - Kyrgyzstan (01-Jan-2021-31-Dec-2023)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Kyrgyzstan, TB/HIV, United Nations Development Programme (UNDP Kyrgyzstan)This program has the following goals: To minimize the impact of the HIV epidemic by reducing 50% of the incidence and mortality by 2023 compared to 2015, as a stage towards eliminating the epidemic in the Kyrgyz Republic by 2030..  Success of treatment among drug resistant forms of MDR-TB by 2023, 75% according to NTP-5.. The objectives of this program are: Reduce the number of new HIV infections, especially among key populations by 70% by 2023 compared to 2015..  Ensure that 90% of people living with HIV (PLHIV) are aware of their HIV status..  Cover 90% of people living with HIV with antiretroviral therapy (ART) and achieve viral load suppression in 90% of people receiving ART by 2023..  Achieve a reduction to less than 2% of mother-to-child transmission of HIV, which will lead to its elimination by 2021..  To reduce the level of stigma and discrimination to zero in government organizations providing HIV-related services to key populations and PLHIV..  Reduce to zero the number of laws, other regulations and practices that discriminate against people living with HIV and key populations..  Ensure coordination and sustainable financing of HIV response measures by gradually increasing the share of government funding for HIV prevention and treatment programs to 60% by 2023..  To ensure universal access to timely and quality diagnosis and treatment of all forms of TB including M/XDR-TB</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="KGZ-C-UNDPP03" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="4" />
		<activity-date type="1" iso-date="2021-01-01" />
		<activity-date type="2" iso-date="2021-01-01" />
		<activity-date type="3" iso-date="2023-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Valeria, GRISHECHKINA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>valeria.grishechkina@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="KG" percentage="100">
			<narrative xml:lang="en">Kyrgyzstan</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="24">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="43">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="2">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="31">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Needle and syringe programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="8">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Case management, clinical operations and therapeutics</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID diagnostics and testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Infection prevention and control, and protection of the health workforce</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Laboratory systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for HIV programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for TB programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Respond to human rights and gender related barriers to services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Surveillance: Epidemiological investigation and contact tracing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="25">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Laboratory systems -&gt; Infrastructure and equipment management systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Laboratory systems -&gt; Quality management systems and accreditation</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="11">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="18">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2023-01-01" />
			<period-end iso-date="2023-12-31" />
			<value currency="USD" value-date="2021-01-01">16389978.49</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2022-01-01" />
			<period-end iso-date="2022-12-31" />
			<value currency="USD" value-date="2021-01-01">10364556.38</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2021-01-01" />
			<period-end iso-date="2021-12-31" />
			<value currency="USD" value-date="2021-01-01">5708999.74</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2021-01-01">1115831.46</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2021-01-01">481931.18</value>
		</budget>
		<transaction ref="3488b213-794e-47a0-a54e-597ba7493c9e">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-11-07" />
			<value currency="USD" value-date="2022-11-07">10761184.86</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="74634a87-c8b6-44dc-baef-92564f4fac4d">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-02-24" />
			<value currency="USD" value-date="2022-02-24">-50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="38ab470f-e8e0-4505-882d-019c84fca03b">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-10-04" />
			<value currency="USD" value-date="2021-10-04">3728604.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2fab1397-3373-4627-8c16-657affd69846">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-07-23" />
			<value currency="USD" value-date="2023-07-23">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4a9fe3be-0638-4bdb-a1f9-2eb38e9ec402">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-08-28" />
			<value currency="USD" value-date="2023-08-28">2121703.01</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4e829052-e1dd-43e4-9423-ecdc69889fd1">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-01-18" />
			<value currency="USD" value-date="2021-01-18">15279192.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="30dfc4b1-ca34-493f-8759-36ea0783f7e1">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-06-30" />
			<value currency="USD" value-date="2022-06-30">1339773.09</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c86b7c2f-f034-472e-b6aa-6cb15053ec3c">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-07-07" />
			<value currency="USD" value-date="2021-07-07">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ac0dda50-205f-446e-8dff-04ba58e2ce6f">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-02-24" />
			<value currency="USD" value-date="2022-02-24">100000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="99886471-9b33-4626-8cf3-7b00b2b430c0">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-09-30" />
			<value currency="USD" value-date="2024-09-30">-39690.23</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="58fd45e2-4131-4058-93d1-9fcfdb63c59d">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-06-27" />
			<value currency="USD" value-date="2025-06-27">-2699416.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a7e7f019-308a-4bb0-853d-d16ec28ae823">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-08-11" />
			<value currency="USD" value-date="2025-08-11">-1676.95</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="71f6b927-53be-469b-9465-d3090d2a4788">
			<transaction-type code="7" />
			<transaction-date iso-date="2025-06-30" />
			<value currency="USD" value-date="2025-06-30">-2699416.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="77ec6920-5fdd-40af-89f2-2b22c4934cb4">
			<transaction-type code="7" />
			<transaction-date iso-date="2025-08-07" />
			<value currency="USD" value-date="2025-08-07">-1676.95</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="59aeecb8-2e7d-4ea8-9965-04099e52311a">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-04-13" />
			<value currency="USD" value-date="2023-04-13">49885.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0fe72bb6-a9a3-41d4-9748-3ba14c2b3a7b">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-03-01" />
			<value currency="USD" value-date="2022-03-01">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ff731615-1778-42a8-b8a4-dd653ffb9c38">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-09-01" />
			<value currency="USD" value-date="2023-09-01">801440.01</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="96da1597-69b9-47eb-9b92-c1caaa297b28">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-11-17" />
			<value currency="USD" value-date="2022-11-17">1145520.95</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d6d52f48-2e1c-4b5f-839f-1bf2a1f5a3fc">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-01-12" />
			<value currency="USD" value-date="2023-01-12">58337.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fe3caed8-cc36-4f61-afae-0ab1db0fbe39">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-01-20" />
			<value currency="USD" value-date="2021-01-20">15279192.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="872eb03d-8c5f-4c67-849d-20aae934c9e7">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-04-11" />
			<value currency="USD" value-date="2023-04-11">1100074.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6803fd70-d2b8-4152-a353-82cd79fd158c">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-09-01" />
			<value currency="USD" value-date="2023-09-01">464504.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="353fe3e4-a133-4b3a-9491-d47853f4c23a">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-01-10" />
			<value currency="USD" value-date="2023-01-10">487033.94</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f68ffd6f-f6ed-465b-b237-bd59ef9bb8bf">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-11-10" />
			<value currency="USD" value-date="2022-11-10">414816.97</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="68e7c7b9-c507-4993-8f76-acb7abe65b07">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-03-21" />
			<value currency="USD" value-date="2023-03-21">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0d1c4115-6bb8-46a3-bba6-4657e3953341">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-07-14" />
			<value currency="USD" value-date="2022-07-14">1339773.09</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f8d5b62d-c6a9-4dff-9734-6d82b1a1f269">
			<transaction-type code="7" />
			<transaction-date iso-date="2024-10-01" />
			<value currency="USD" value-date="2024-10-01">-39690.23</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d3700ac0-a3a4-49f2-bd06-a979a66d27cd">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-04-07" />
			<value currency="USD" value-date="2022-04-07">105302.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="75b506f5-af87-4a7a-88a2-4ea7d2e3fc92">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-01-06" />
			<value currency="USD" value-date="2022-01-06">141476.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="98897149-6330-4a4e-8610-be9a5b4680bd">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-01-05" />
			<value currency="USD" value-date="2023-01-05">7505517.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="23565fc6-e636-4d7c-ac2a-0b151fb0a8bf">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-10-10" />
			<value currency="USD" value-date="2023-10-10">49886.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2808db75-f4be-4d48-9eae-23417d11c049">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-04-11" />
			<value currency="USD" value-date="2024-04-11">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f9612414-5f44-4201-9cf7-923e4d30e123">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-10-10" />
			<value currency="USD" value-date="2023-10-10">805873.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4786e86b-e168-4c9f-bee3-16cec318835e">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-10-07" />
			<value currency="USD" value-date="2021-10-07">3481826.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to KGZ-C-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Kyrgyzstan)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/KGZ-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for KGZ-C-UNDPP03</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.00" />
					<actual value="48.60" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="75.00" />
					<actual value="53.20" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="75.00" />
					<actual value="54.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="71.62" />
					<actual value="54.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="57.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="71.60" />
					<actual value="54.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="81.30" />
					<actual value="54.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="81.33" />
					<actual value="54.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="5000" />
					<actual value="4422" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="5000" />
					<actual value="7159" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="5000" />
					<actual value="4625" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="5000" />
					<actual value="4422" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="5000" />
					<actual value="4625" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="5000" />
					<actual value="7159" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of confirmed RR/MDR-TB cases tested for resistance to second-line drugs</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="72.00" />
					<actual value="79.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.00" />
					<actual value="86.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="75.00" />
					<actual value="86.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.20" />
					<actual value="81.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.25" />
					<actual value="81.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="77.43" />
					<actual value="65.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="77.40" />
					<actual value="65.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.40" />
					<actual value="62.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.39" />
					<actual value="62.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="70.40" />
					<actual value="65.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="60.00" />
					<actual value="45.40" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="63.35" />
					<actual value="54.10" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="70.39" />
					<actual value="65.70" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="63.40" />
					<actual value="54.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.00" />
					<actual value="67.90" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.00" />
					<actual value="79.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="72.00" />
					<actual value="69.50" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1850" />
					<actual value="768" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="1697" />
					<actual value="914" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1832" />
					<actual value="858" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="63.00" />
					<actual value="64.40" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="63.04" />
					<actual value="64.40" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="55.04" />
					<actual value="56.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="71.00" />
					<actual value="70.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="71.04" />
					<actual value="70.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="55.00" />
					<actual value="56.30" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1850" />
					<actual value="776" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="1612" />
					<actual value="934" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1832" />
					<actual value="904" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="98.00" />
					<actual value="95.10" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="99.00" />
					<actual value="95.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="97.00" />
					<actual value="94.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="71.01" />
					<actual value="62.10" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="71.00" />
					<actual value="62.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="60.00" />
					<actual value="61.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="60.00" />
					<actual value="53.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of eligible men who have sex with men who initiated oral antiretroviral PrEP during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="150" />
					<actual value="261" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="150" />
					<actual value="33" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="150" />
					<actual value="147" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people newly diagnosed with HIV initiated on ART</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="89.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="90.00" />
					<actual value="87.90" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="90.00" />
					<actual value="92.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.00" />
					<actual value="93.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="73.96" />
					<actual value="74.40" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="76.90" />
					<actual value="85.60" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="74.00" />
					<actual value="74.40" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="76.92" />
					<actual value="85.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="94.00" />
					<actual value="95.20" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="95.00" />
					<actual value="96.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="96.00" />
					<actual value="99.10" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for KGZ-C-UNDPP03</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="85.00" />
					<actual value="2839" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="89.00" />
					<actual value="3121" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="87.00" />
					<actual value="3121" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="60.00" />
					<actual value="70.94" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="65.00" />
					<actual value="70.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="70.00" />
					<actual value="70.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="70.00" />
					<actual value="72.38" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="65.00" />
					<actual value="72.38" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="88.00" />
					<actual value="54.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="53.12" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="89.00" />
					<actual value="53.12" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reporting using sterile injecting equipment the last time they injected</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="83.00" />
					<actual value="96.40" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men reporting using a condom the last time they had anal sex with a male partner</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="81.00" />
					<actual value="88.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV who know their HIV status at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="77.72" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="90.00" />
					<actual value="77.72" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="77.72" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="82.17" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="82.17" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV and on ART who are virologically suppressed</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="95.90" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="95.90" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="90.00" />
					<actual value="95.90" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="92.24" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="92.24" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reporting using a condom with their most recent client</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="97.00" />
					<actual value="93.04" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people diagnosed with TB who report stigma in community settings that inhibited them from seeking and accessing TB services</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="10.00" />
					<actual value="38.84" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for KGZ-C-UNDPP03</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="10.00" />
					<actual value="16.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="6.00" />
					<actual value="10.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="29.00" />
					<actual value="25.88" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="28.50" />
					<actual value="23.28" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="28.00" />
					<actual value="23.28" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of AIDS-related deaths per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="3.89" />
					<actual value="3.06" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="3.23" />
					<actual value="1.49" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="3.23" />
					<actual value="1.49" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="3.6" />
					<actual value="3.87" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="3" />
					<actual value="2.25" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="3.3" />
					<actual value="2.25" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="2.00" />
					<actual value="3.38" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>